title: Why patients who die of worsening pulmonary arterial hypertension are not on parenteral prostacyclin analog treatment?
authors.affiliation: Department of Pulmonary and Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio.
authors.forename: Adriano R
authors.initials: AR
authors.lastname: Tonelli
authors.affiliation: Department of Pulmonary and Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio.
authors.forename: Raed A
authors.initials: RA
authors.lastname: Dweik
mesh_terms: D019468:Disease Management; D018450:Disease Progression; D065128:Endothelin Receptor Antagonists; D011464:Epoprostenol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000145:classification* / Q000188:drug therapy*; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use*
chemical_list: D065128:Endothelin Receptor Antagonists; D058986:Phosphodiesterase 5 Inhibitors; D011464:Epoprostenol